China's First Rare-disease Registry is Under Development
Overview
Affiliations
Lv S, Zhao J, Xi L, Lin X, Wang C, Yue H Front Cell Dev Biol. 2021; 9:715042.
PMID: 34557487 PMC: 8452955. DOI: 10.3389/fcell.2021.715042.
Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China.
Li X, Peng X, Gong C Chin Med J (Engl). 2018; 131(19):2388-2389.
PMID: 30246737 PMC: 6166461. DOI: 10.4103/0366-6999.241814.
Next generation sequencing: Coping with rare genetic diseases in China.
Cram D, Zhou D Intractable Rare Dis Res. 2016; 5(3):140-4.
PMID: 27672536 PMC: 4995420. DOI: 10.5582/irdr.2016.01020.
Rare genetic disease in China: a call to improve clinical services.
Chopra M, Duan T Orphanet J Rare Dis. 2015; 10:140.
PMID: 26515493 PMC: 4625436. DOI: 10.1186/s13023-015-0333-7.
Study and analysis of the state of rare disease research in Shandong Province, China.
Zhao H, Cui Y, Zhou X, Pang J, Zhang X, Xu S Intractable Rare Dis Res. 2014; 1(4):161-6.
PMID: 25343091 PMC: 4204566. DOI: 10.5582/irdr.2012.v1.4.161.